Citation: Smith, S., Dworkin, R., Turk, D., Baron, R., Polydefkis, M., Tracey, I.,  Borsook, D., Edwards, R., Harris, R., Wager, T., Arendt-Nielsen, L., Burke, L., Carr, D., Chappell, A., Farrar, J., Freeman, R., Gilron, I., Goli, V., Haeussler, J., Jensen, T., Katz, N., Kent, J., Kopecky, E., Lee, D., Maixner, W., Markman, J., McArthur, J., McDermott, M., Parvathenani, L., Raja, S., Rappaport, B., Rice, A., Rowbotham, M., Tobias, J., Wasan, A., Witter, J., (2017). The potential role of sensory testing, skin biopsy, and functional brain imaging as biomarkers in chronic pain clinical trials: IMPACT considerations. Journal of Pain.

Full Text